The Albany International Airport has completed the first phase of its Concourse A Rehabilitation Project. Phase one included ...

Lilly’s orforglipron cut body weight as expected in the Phase III ATTAIN-1 trial, but to a lesser extent than rival Novo ...

It looks likely we'll see oral GLP-1 drugs on the market by next year, with pharmaceutical company Eli Lilly reporting ...

VALORANT’s Esports Product Manager has revealed a list of tournaments which will offer direct qualification to Project ...

Ucore Rare Metals Inc. (OTCMKTS:UURAF) is one of the best rare earth stocks to buy now. On July 14, the company confirmed all ...

The Pension Fund Regulatory and Development Authority has published 40 vacancies for the recruitment of Officer Grade ‘A’ ...

The African Development Bank (AFDB) said Phase 2 of its Special Agro-Industrial Processing Zones, which will cover the remaining 28 States, is scheduled to take off from September 2025.

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

NDA for icotrokinra for the treatment of adults and adolescents 12 years of age and older with moderate to severe plaque ...

Almost half of the primary schools in Singapore were oversubscribed in Phase 2C of the Primary 1 registration exercise this ...

Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight ...